Publications
Search in 13051 publications:
13051 Publication(s)
Trampolinspringen: Spass haben - aber sicher!
Toepfer A. Trampolinspringen: Spass haben - aber sicher!. MMW Fortschritte der Medizin 2019:19-19.
Nov 27, 2019Trampolinspringen: Spass haben - aber sicher!
Nov 27, 2019MMW Fortschritte der Medizin 2019:19-19
Toepfer Andreas
The inguinal region revisited: the surgical point of view : An anatomical-surgical mapping and sonographic approach regarding postoperative chronic groin pain following open hernia repair
Konschake M, Zwierzina M, Moriggl B, Függer R, Mayer F, Brunner W, Schmid T, Chen D, Fortelny R. The inguinal region revisited: the surgical point of view : An anatomical-surgical mapping and sonographic approach regarding postoperative chronic groin pain following open hernia repair. Hernia 2019; 24:883-894.
Nov 27, 2019The inguinal region revisited: the surgical point of view : An anatomical-surgical mapping and sonographic approach regarding postoperative chronic groin pain following open hernia repair
Nov 27, 2019Hernia 2019; 24:883-894
Konschake M, Zwierzina M, Moriggl B, Függer R, Mayer F, Brunner Walter, Schmid T, Chen D C, Fortelny R
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
van den Bent M, Zhang H, Balbin O, Vicente S, Cheng Y, Kirsilae T, Zhao S, Tiedt R, Rodón J, Tabatabai G, Jörger M, Lassman A, Wen P, Yung W, Sepulveda J, De Vos F, Azaro A, Wick W. A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma. J Neurooncol 2019
Nov 27, 2019A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Nov 27, 2019J Neurooncol 2019
van den Bent Martin, Zhang Hefei, Balbin O Alejandro, Vicente Sergio, Cheng Yi, Kirsilae Tiina, Zhao Sylvia, Tiedt Ralph, Rodón Jordi, Tabatabai Ghazaleh, Jörger Markus, Lassman Andrew B, Wen Patrick Y, Yung W K Alfred, Sepulveda Juan, De Vos Filip, Azaro Analia, Wick Wolfgang
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Antonarakis E, Procopio G, Fukasawa S, Tabata K, Park S, Feyerabend S, Drake C, Wu H, Qiu P, Kim J, Poehlein C, Omlin A, Li C, Piulats J, Gross-Goupil M, Goh J, Ojamaa K, Hoimes C, Vaishampayan U, Berger R, Sezer A, Alanko T, de Wit R, de Bono J. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study. J Clin Oncol 2019:JCO1901638.
Nov 27, 2019Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Nov 27, 2019J Clin Oncol 2019:JCO1901638
Antonarakis Emmanuel S, Procopio Giuseppe, Fukasawa Satoshi, Tabata Ken-Ichi, Park Se Hoon, Feyerabend Susan, Drake Charles G, Wu Haiyan, Qiu Ping, Kim Jeri, Poehlein Christian, Omlin Aurelius, Li Chunde, Piulats Josep M, Gross-Goupil Marine, Goh Jeffrey, Ojamaa Kristiina, Hoimes Christopher J, Vaishampayan Ulka, Berger Ranaan, Sezer Ahmet, Alanko Tuomo, de Wit Ronald, de Bono Johann Sebastian
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function
Lercher A, Pikor N, Reil D, Ozsvár-Kozma M, Kalinke U, Ludewig B, Moriggl R, Bennett K, Menche J, Cheng P, Schabbauer G, Trauner M, Klavins K, Orlova A, Genger J, Bhattacharya A, Popa A, Caldera M, Schlapansky M, Baazim H, Agerer B, Gürtl B, Kosack L, Májek P, Brunner J, Vitko D, Pinter T, Bergthaler A. Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function. Immunity 2019; 51:1074-1087.e9.
Nov 26, 2019Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function
Nov 26, 2019Immunity 2019; 51:1074-1087.e9
Lercher Alexander, Pikor Natalia, Reil Daniela, Ozsvár-Kozma Maria, Kalinke Ulrich, Ludewig Burkhard, Moriggl Richard, Bennett Keiryn L, Menche Jörg, Cheng Paul N, Schabbauer Gernot, Trauner Michael, Klavins Kristaps, Orlova Anna, Genger Jakob-Wendelin, Bhattacharya Anannya, Popa Alexandra M, Caldera Michael, Schlapansky Moritz F, Baazim Hatoon, Agerer Benedikt, Gürtl Bettina, Kosack Lindsay, Májek Peter, Brunner Julia S, Vitko Dijana, Pinter Theresa, Bergthaler Andreas
Fortschritte in der Therapie des akuten ischämischen Schlaganfalls
Velicky M, Fluri F. Fortschritte in der Therapie des akuten ischämischen Schlaganfalls - Progrès dans le traitement de l'AVC ischémique aigu. Physioactive 2019:5-9.
Nov 25, 2019Fortschritte in der Therapie des akuten ischämischen Schlaganfalls
Nov 25, 2019Physioactive 2019:5-9
Velicky Matus, Fluri Felix
Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients
Vrabel D, Sevcikova S, Pour L, Stork M, Sandecka V, Jelinek T, Plonkova H, Jarkovsky J, Brožová L, Kubaczkova V, Almasi M, Bezdekova R, Rihova L, Besse L, Sedlarikova L, Hájek R. Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients. Eur J Haematol 2019
Nov 25, 2019Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients
Nov 25, 2019Eur J Haematol 2019
Vrabel David, Sevcikova Sabina, Pour Ludek, Stork Martin, Sandecka Viera, Jelinek Tomas, Plonkova Hana, Jarkovsky Jiri, Brožová Lucie, Kubaczkova Veronika, Almasi Martina, Bezdekova Renata, Rihova Lucie, Besse Lenka, Sedlarikova Lenka, Hájek Roman
Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.
Traenka C, Grond-Ginsbach C, Simonetti B, Metso T, Debette S, Pezzini A, Kloss M, Majersik J, Southerland A, Leys D, Baumgartner R, Caso V, Béjot Y, De Marchis G, Fischer U, Polymeris A, Sarikaya H, Thijs V, Worrall B, Bersano A, Brandt T, Gensicke H, Bonati L, Touzeé E, Gilmartin J, Chabriat H, Tatlisumak T, Arnold M, Engelter S, Lyrer P, CADISP-Plus Study Group. Artery occlusion independently predicts unfavorable outcome in cervical artery dissection. Neurology 2019; 94:e170-e180.
Nov 22, 2019Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.
Nov 22, 2019Neurology 2019; 94:e170-e180
Traenka Christopher, Grond-Ginsbach Caspar, Simonetti Barbara Goeggel, Metso Tiina M, Debette Stephanie, Pezzini Alessandro, Kloss Manja, Majersik Jennifer J, Southerland Andrew M, Leys Didier, Baumgartner Ralf Werner, Caso Valeria, Béjot Yannick, De Marchis Gian Marco, Fischer Urs, Polymeris Alexandros A, Sarikaya Hakan, Thijs Vincent, Worrall Bradford B, Bersano Anna, Brandt Tobias, Gensicke Henrik, Bonati Leo H, Touzeé Emmanuel, Gilmartin John J, Chabriat Hugues, Tatlisumak Turgut, Arnold Marcel, Engelter Stefan T, Lyrer Philippe A, CADISP-Plus Study Group
Timing of Adjuvant Radiation Therapy and Risk of Wound-Related Complications Among Patients With Spinal Metastatic Disease
Azad T, Ratliff J, Veeravagu A, Bagshaw H, Zygourakis C, Stienen M, Ho A, Pendharkar A, Herrick D, Varshneya K, Desai A. Timing of Adjuvant Radiation Therapy and Risk of Wound-Related Complications Among Patients With Spinal Metastatic Disease. Global Spine J 2019; 11:44-49.
Nov 22, 2019Timing of Adjuvant Radiation Therapy and Risk of Wound-Related Complications Among Patients With Spinal Metastatic Disease
Nov 22, 2019Global Spine J 2019; 11:44-49
Azad Tej D, Ratliff John K, Veeravagu Anand, Bagshaw Hilary P, Zygourakis Corinna, Stienen Martin N., Ho Allen L, Pendharkar Arjun V, Herrick Daniel B, Varshneya Kunal, Desai Atman
Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study
Corinne C, Sulz M, Scherz N, Tandjung R, Zahnd N, Rogler G, Rosemann T, Hasler S, Senn O, Vavricka S. Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study. PloS one 2019; 14:e0224961.
Nov 21, 2019Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study
Nov 21, 2019PloS one 2019; 14:e0224961
Corinne Chmiel, Sulz Michael, Scherz Nathalie, Tandjung Ryan, Zahnd Nadine, Rogler Gerhard, Rosemann Thomas, Hasler Susann, Senn Oliver, Vavricka Stephan
Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB)
Habibi I, El Matri L, El Matri K, Turki A, Helfenstein M, Vaclavik V, Wyrsch S, Todorova M, Falfoul Y, Schorderet D. Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB). Genes 2019; 10:1-17.
Nov 21, 2019Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB)
Nov 21, 2019Genes 2019; 10:1-17
Habibi Imen, El Matri Leila, El Matri Khaled, Turki Ahmed, Helfenstein Maria, Vaclavik Veronika, Wyrsch Stefan, Todorova Margarita, Falfoul Yosra, Schorderet Daniel F.
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.
Jacobs B, Deenen M, Joerger M, Rosing H, de Vries N, Meulendijks D, Cats A, Beijnen J, Schellens J, Huitema A. Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis. CPT Pharmacometrics Syst Pharmacol 2019; 8:940-950.
Nov 20, 2019Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.
Nov 20, 2019CPT Pharmacometrics Syst Pharmacol 2019; 8:940-950
Jacobs Bart A W, Deenen Maarten J, Joerger Markus, Rosing Hilde, de Vries Niels, Meulendijks Didier, Cats Annemieke, Beijnen Jos H, Schellens Jan H M, Huitema Alwin D R
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
Khoo V, N'Dow J, Necchi A, Neuzillet Y, Oddens J, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel M, Pieters B, Plass K, Remzi M, Müller C, Müller A, Kiltie A, Krege S, Ladoire S, Lara P, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir M, Moschini M, Mostafid H, Retz M, Richenberg J, Turkbey B, Lauridsen S, Valdagni R, Der Heijden A, Van Poppel H, Vartolomei M, Veskimäe E, Vilaseca A, Rivera F, Wiegel T, Wiklund P, Williams A, Zigeuner R, Tombal B, Thalmann G, Rink M, Roghmann F, Rosenberg J, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk R, Smits A, Stenzl A, Horwich A, Kamat A, Witjes J, Arends T, Bamias A, Birtle A, Black P, Bochner B, Bolla M, Boormans J, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Agarwal N, Xylinas E, Babjuk M, Bellmunt J, Bruins H, de Reijke T, De Santis M, Gillessen Sommer S, James N, MacLennan S, Palou J, Powles T, Ribal M, Shariat S, Der Kwast T, Chiti A, Choudhury A, Gontero P, Grubmüller B, Hafeez S, Hansel D, Hartmann A, Hayne D, Henry A, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa B, Geavlete B, Gakis G, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig J, Fanti S, Fonteyne V, Frydenberg M, Futterer J, Jones R. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol 2019; 77:223-250.
Nov 19, 2019EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
Nov 19, 2019Eur Urol 2019; 77:223-250
Khoo Vincent, N'Dow James, Necchi Andrea, Neuzillet Yann, Oddens Jorg R, Oldenburg Jan, Osanto Susanne, J G Oyen Wim, Pacheco-Figueiredo Luís, Pappot Helle, Patel Manish I, Pieters Bradley R, Plass Karin, Remzi Mesut, Müller Christoph R, Müller Arndt-Christian, Kiltie Anne E, Krege Susanne, Ladoire Sylvain, Lara Pedro C, Leliveld Annemarie, Linares-Espinós Estefania, Løgager Vibeke, Lorch Anja, Loriot Yohann, Meijer Richard, Mir M Carmen, Moschini Marco, Mostafid Hugh, Retz Margitta, Richenberg Jonathan, Turkbey Baris, Lauridsen Susanne Vahr, Valdagni Riccardo, Der Heijden Antoine G Van, Van Poppel Hein, Vartolomei Mihai D, Veskimäe Erik, Vilaseca Antoni, Rivera Franklin A Vives, Wiegel Thomas, Wiklund Peter, Williams Andrew, Zigeuner Richard, Tombal Bertrand, Thalmann George N, Rink Michael, Roghmann Florian, Rosenberg Jonathan E, Rouprêt Morgan, Rouvière Olivier, Salembier Carl, Salminen Antti, Sargos Paul, Sengupta Shomik, Sherif Amir, Smeenk Robert J, Smits Anita, Stenzl Arnulf, Horwich Alan, Kamat Ashish M, Witjes J Alfred, Arends Tom, Bamias Aristotle, Birtle Alison, Black Peter C, Bochner Bernard H, Bolla Michel, Boormans Joost L, Bossi Alberto, Briganti Alberto, Brummelhuis Iris, Burger Max, Castellano Daniel, Cathomas Richard, Agarwal Neeraj, Xylinas Evanguelos, Babjuk Marek, Bellmunt Joaquim, Bruins H Maxim, de Reijke Theo M, De Santis Maria, Gillessen Sommer Silke, James Nicholas, MacLennan Steven, Palou Juan, Powles Tom, Ribal Maria J, Shariat Shahrokh F, Der Kwast Theo Van, Chiti Arturo, Choudhury Ananya, Gontero Paolo, Grubmüller Bernhard, Hafeez Shaista, Hansel Donna E, Hartmann Arndt, Hayne Dickon, Henry Ann M, Hernandez Virginia, Herr Harry, Herrmann Ken, Hoskin Peter, Huguet Jorge, Jereczek-Fossa Barbara A, Geavlete Bogdan, Gakis Georgios, Compérat Eva, Crabb Simon, Culine Stéphane, De Bari Berardino, De Blok Willem, J L De Visschere Pieter, Decaestecker Karel, Dimitropoulos Konstantinos, Dominguez-Escrig Jose L, Fanti Stefano, Fonteyne Valerie, Frydenberg Mark, Futterer Jurgen J, Jones Rob
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
Nordmann T, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger S, Rordorf T, Mangana J, Braun R, Dummer R. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease. Oncotarget 2019; 10:6647-6650.
Nov 19, 2019Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
Nov 19, 2019Oncotarget 2019; 10:6647-6650
Nordmann Thierry M, Messerli-Odermatt Olivia, Meier Larissa, Micaletto Sara, Coppetti Thomas, Nägeli Mirjam, Kamarachev Jivko, Kudura Ken, Freiberger Sandra N, Rordorf Tamara, Mangana Joanna, Braun Ralph, Dummer Reinhard
Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC
Schett A, Rothschild S, Curioni-Fontecedro A, Krähenbühl S, Früh M, Schmid S, Driessen C, Jörger M. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC. Cancer Chemother Pharmacol 2019; 85:121-131.
Nov 19, 2019Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC
Nov 19, 2019Cancer Chemother Pharmacol 2019; 85:121-131
Schett Anne, Rothschild Sacha I, Curioni-Fontecedro Alessandra, Krähenbühl Stephan, Früh Martin, Schmid S, Driessen Christoph, Jörger Markus
Catheter-related bloodstream infections due to coagulase-negative staphylococci managed with catheter removal: Recurrences are rare
Hebeisen U, Babouee Flury B, Atkinson A, Marschall J, Buetti N. Catheter-related bloodstream infections due to coagulase-negative staphylococci managed with catheter removal: Recurrences are rare. Am J Infect Control 2019; 48:837-839.
Nov 19, 2019Catheter-related bloodstream infections due to coagulase-negative staphylococci managed with catheter removal: Recurrences are rare
Nov 19, 2019Am J Infect Control 2019; 48:837-839
Hebeisen Ursula, Babouee Flury Baharak, Atkinson Andrew, Marschall Jonas, Buetti Niccolo
Nano-analytical characterization of endogenous minerals in healthy placental tissue: mineral distribution, composition and ultrastructure
Anthis A, Chavatte-Palmer P, Jochum W, Wick P, Dommann A, Bürki-Turnherr T, Fischer T, Hornung R, Bertazzo S, Lehner S, Wildermuth S, Leschka S, Tsolaki E, Didierlaurent L, Staubli S, Zboray R, Neels A, Dietrich D, Manser P, Desbiolles L, Herrmann I. Nano-analytical characterization of endogenous minerals in healthy placental tissue: mineral distribution, composition and ultrastructure. Analyst 2019; 144:6850-6857.
Nov 18, 2019Nano-analytical characterization of endogenous minerals in healthy placental tissue: mineral distribution, composition and ultrastructure
Nov 18, 2019Analyst 2019; 144:6850-6857
Anthis Alexandre H C, Chavatte-Palmer Pascale, Jochum Wolfram, Wick Peter, Dommann Alex, Bürki-Turnherr Tina, Fischer Tina, Hornung René, Bertazzo Sergio, Lehner Sandro, Wildermuth Simon, Leschka Sebastian, Tsolaki Elena, Didierlaurent Louis, Staubli Samuel, Zboray Robert, Neels Antonia, Dietrich Dörthe, Manser Pius, Desbiolles Lotus May, Herrmann Inge K
Prehospital Spine Management - skip the collar!
Maschmann C (2019). Prehospital Spine Management - skip the collar!. Presented at: Nordic Neurotrauma Conference 2019, Lund, Sweden
Nov 18, 2019Prehospital Spine Management - skip the collar!
Nov 18, 2019Nordic Neurotrauma Conference 2019
Maschmann Christian
Polyglobulie bei Missbrauch von androgenen anabolen Steroiden
Brändle M. Polyglobulie bei Missbrauch von androgenen anabolen Steroiden - Was hat «Das Schwarze Buch» mit Aderlass zu tun?. Swiss Med Forum 2019; 19:655-658.
Nov 17, 2019Polyglobulie bei Missbrauch von androgenen anabolen Steroiden
Nov 17, 2019Swiss Med Forum 2019; 19:655-658
Brändle Michael
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial
Witzel I, Untch M, Stickeler E, Schem C, Marme F, Mackelenbergh M, Karn T, Huober J, Lück H, Weber K, Denkert C, Fasching P, Wirtz R, Loibl S, Müller V. Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial. Br J Cancer 2019; 121:1009-1015.
Nov 15, 2019Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial
Nov 15, 2019Br J Cancer 2019; 121:1009-1015
Witzel Isabell, Untch Michael, Stickeler Elmar, Schem Christian, Marme Frederik, Mackelenbergh Marion von, Karn Thomas, Huober Jens, Lück Hans-Joachim, Weber Karsten, Denkert Carsten, Fasching Peter A, Wirtz Ralph, Loibl Sibylle, Müller Volkmar